| Amber Snow, APRN | |
|
353 Blair Park Rd, Williston, VT 05495-7530 | |
| (802) 847-1470 | |
| Not Available |
| Full Name | Amber Snow |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 353 Blair Park Rd, Williston, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356711659 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
Fibromyalgia is the second most common rheumatic disorder behind osteoarthritis and, though still widely misunderstood, is now considered to be a lifelong central nervous system disorder, which is responsible for amplified pain that shoots through the body in those who suffer from it.
Aestus Therapeutics, Inc., announced today that it has initiated screening of patients for a clinical trial to evaluate the efficacy of its novel pain therapeutic, ATx08-001. This placebo-controlled, two-dose level study will test the efficacy of ATx08-001 in reducing the pain following an outbreak of shingles.
A new study reveals an attractive new target for therapies aimed at the treatment of obesity and related metabolic disorders, researchers report in the March Cell Metabolism.
About 56% of U.S. adults support easing restrictions on federal funding for human embryonic stem cell research, according to an Associated Press-AOL poll conducted from Dec. 19, 2006, to Dec. 21, 2006, the AP/Washington Post reports (Superville, AP/Washington Post, 1/3).
A specific and remarkably small fragment of RNA appears to protect rats against cocaine addiction-and may also protect humans, according to a recent study funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. The study was published today in the journal Nature.
› Verified 4 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Fibromyalgia is the second most common rheumatic disorder behind osteoarthritis and, though still widely misunderstood, is now considered to be a lifelong central nervous system disorder, which is responsible for amplified pain that shoots through the body in those who suffer from it.
Aestus Therapeutics, Inc., announced today that it has initiated screening of patients for a clinical trial to evaluate the efficacy of its novel pain therapeutic, ATx08-001. This placebo-controlled, two-dose level study will test the efficacy of ATx08-001 in reducing the pain following an outbreak of shingles.
A new study reveals an attractive new target for therapies aimed at the treatment of obesity and related metabolic disorders, researchers report in the March Cell Metabolism.
About 56% of U.S. adults support easing restrictions on federal funding for human embryonic stem cell research, according to an Associated Press-AOL poll conducted from Dec. 19, 2006, to Dec. 21, 2006, the AP/Washington Post reports (Superville, AP/Washington Post, 1/3).
A specific and remarkably small fragment of RNA appears to protect rats against cocaine addiction-and may also protect humans, according to a recent study funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. The study was published today in the journal Nature.
› Verified 4 days ago
| Entity Name | University Of Vermont Nursing And Health Sciences Practice Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679986327 PECOS PAC ID: 4587885728 Enrollment ID: O20141031001477 |
News Archive
Fibromyalgia is the second most common rheumatic disorder behind osteoarthritis and, though still widely misunderstood, is now considered to be a lifelong central nervous system disorder, which is responsible for amplified pain that shoots through the body in those who suffer from it.
Aestus Therapeutics, Inc., announced today that it has initiated screening of patients for a clinical trial to evaluate the efficacy of its novel pain therapeutic, ATx08-001. This placebo-controlled, two-dose level study will test the efficacy of ATx08-001 in reducing the pain following an outbreak of shingles.
A new study reveals an attractive new target for therapies aimed at the treatment of obesity and related metabolic disorders, researchers report in the March Cell Metabolism.
About 56% of U.S. adults support easing restrictions on federal funding for human embryonic stem cell research, according to an Associated Press-AOL poll conducted from Dec. 19, 2006, to Dec. 21, 2006, the AP/Washington Post reports (Superville, AP/Washington Post, 1/3).
A specific and remarkably small fragment of RNA appears to protect rats against cocaine addiction-and may also protect humans, according to a recent study funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. The study was published today in the journal Nature.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amber Snow, APRN 1 Delaware St, South Burlington, VT 05403-6437 Ph: (802) 338-7017 | Amber Snow, APRN 353 Blair Park Rd, Williston, VT 05495-7530 Ph: (802) 847-1470 |
News Archive
Fibromyalgia is the second most common rheumatic disorder behind osteoarthritis and, though still widely misunderstood, is now considered to be a lifelong central nervous system disorder, which is responsible for amplified pain that shoots through the body in those who suffer from it.
Aestus Therapeutics, Inc., announced today that it has initiated screening of patients for a clinical trial to evaluate the efficacy of its novel pain therapeutic, ATx08-001. This placebo-controlled, two-dose level study will test the efficacy of ATx08-001 in reducing the pain following an outbreak of shingles.
A new study reveals an attractive new target for therapies aimed at the treatment of obesity and related metabolic disorders, researchers report in the March Cell Metabolism.
About 56% of U.S. adults support easing restrictions on federal funding for human embryonic stem cell research, according to an Associated Press-AOL poll conducted from Dec. 19, 2006, to Dec. 21, 2006, the AP/Washington Post reports (Superville, AP/Washington Post, 1/3).
A specific and remarkably small fragment of RNA appears to protect rats against cocaine addiction-and may also protect humans, according to a recent study funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. The study was published today in the journal Nature.
› Verified 4 days ago
Ms. Shannon R Russom, N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 353 Blair Park Rd, Williston, VT 05495 Phone: 802-847-1600 Fax: 802-847-7184 | |
Ms. Rebecca Brooklyn, APRN Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 4185 St George Rd, Williston, VT 05495 Phone: 802-922-2520 Fax: 802-879-5335 | |
Amy Denis, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 586 Oak Hill Rd, Williston, VT 05495 Phone: 802-878-8131 | |
Anastasiya Lulic, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 586 Oak Hill Rd, Williston, VT 05495 Phone: 802-878-8131 | |
Ms. Jena S Katzman, APRN, FNP Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 586 Oak Hill Rd, Williston, VT 05495 Phone: 802-878-8131 Fax: 802-879-6853 | |
Karyn Harvey Farevaag, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 353 Blair Park Rd, Williston, VT 05495 Phone: 802-847-1470 | |
Jessica Jawidzik, APRN, DNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4185 St George Rd, Williston, VT 05495 Phone: 802-266-4465 Fax: 802-531-3226 |